NASDAQ:IMGN

ImmunoGen SEC Filings & 10K Form

$6.51
-0.82 (-11.19 %)
(As of 05/10/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.44
$7.01
50-Day Range
$7.08
$8.68
52-Week Range
$3.38
$10.88
Volume2.24 million shs
Average Volume2.26 million shs
Market Capitalization$1.30 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.65

SEC Filings

ImmunoGen (NASDAQ:IMGN) SEC Filings

DateFilerForm TypeView
05/10/2021
5:36 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2021
12:02 PM
Goldberg Mark Alan (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
12:01 PM
ImmunoGen (Issuer)
MITCHELL DEAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
5:37 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2021
10:03 AM
ImmunoGen (Subject)
Form SC 13G/A
02/09/2021
7:13 PM
Enyedy Mark J (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:11 PM
ALTSCHULLER Susan (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:11 PM
ImmunoGen (Issuer)
Wingrove Theresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:11 PM
Coen Stacy Ann (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:10 PM
ImmunoGen (Issuer)
Lentini Renee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:09 PM
Berkenblit Anna (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
4:20 PM
Clearbridge Investments, LLC (Filed by)
ImmunoGen (Subject)
Form SC 13G/A
02/08/2021
9:25 AM
FMR LLC (Filed by)
ImmunoGen (Subject)
Form SC 13G
02/04/2021
8:37 AM
ImmunoGen (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/29/2021
8:57 AM
BlackRock Inc. (Filed by)
ImmunoGen (Subject)
Form SC 13G/A
01/11/2021
3:50 PM
ImmunoGen (Issuer)
Lentini Renee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:49 PM
ImmunoGen (Issuer)
Lentini Renee (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2021
6:01 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
7:59 AM
ImmunoGen (Issuer)
Wingrove Theresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
7:59 AM
FOSTER DAVID G (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
7:58 AM
Berkenblit Anna (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
4:32 PM
FOSTER DAVID G (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
9:46 AM
Goldberg Mark Alan (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
9:45 AM
ImmunoGen (Issuer)
MITCHELL DEAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
3:58 PM
ImmunoGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/18/2020
4:19 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
4:16 PM
ImmunoGen (Filer)
Form 424B5
12/18/2020
3:45 PM
ImmunoGen (Filer)
Form S-3ASR
12/18/2020
3:16 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2020
3:40 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
7:02 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2020
7:38 AM
ImmunoGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2020
5:53 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
8:22 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2020
7:57 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
7:11 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
1:39 PM
Goldberg Mark Alan (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
1:38 PM
ImmunoGen (Issuer)
MITCHELL DEAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2020
3:38 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2020
3:23 PM
ImmunoGen (Filer)
Form 424B5
08/05/2020
12:39 PM
ImmunoGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2020
3:10 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2020
2:44 PM
ALTSCHULLER Susan (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
2:43 PM
ALTSCHULLER Susan (Reporting)
ImmunoGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2020
7:45 AM
ImmunoGen (Issuer)
Wingrove Theresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:44 AM
FOSTER DAVID G (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:41 AM
Enyedy Mark J (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:39 AM
Berkenblit Anna (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:37 AM
ImmunoGen (Issuer)
Ryll Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:35 AM
ImmunoGen (Issuer)
MITCHELL DEAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:34 AM
Goldberg Mark Alan (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
7:15 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2020
12:09 PM
Coen Stacy Ann (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2020
12:08 PM
Coen Stacy Ann (Reporting)
ImmunoGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/03/2020
7:36 AM
ImmunoGen (Filer)
Form DEFA14A
05/05/2020
2:18 PM
ImmunoGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2020
5:35 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2020
3:27 PM
ImmunoGen (Filer)
Form CT ORDER
04/28/2020
10:46 AM
ImmunoGen (Filer)
Form DEFA14A
04/28/2020
10:44 AM
ImmunoGen (Filer)
Form DEF 14A
04/02/2020
2:56 PM
FOSTER DAVID G (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
6:51 AM
ImmunoGen (Issuer)
MITCHELL DEAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
6:51 AM
Goldberg Mark Alan (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
7:38 AM
ImmunoGen (Issuer)
Ryll Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
7:38 AM
Enyedy Mark J (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
7:37 AM
Berkenblit Anna (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
7:37 AM
ImmunoGen (Issuer)
Wingrove Theresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
7:36 AM
BARROWS CRAIG (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:46 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
11:38 AM
Clearbridge Investments, LLC (Filed by)
ImmunoGen (Subject)
Form SC 13G/A
02/14/2020
5:36 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
2:03 PM
ImmunoGen (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/11/2020
8:27 AM
FOSTER DAVID G (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
8:27 AM
ImmunoGen (Issuer)
Wingrove Theresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
8:26 AM
Enyedy Mark J (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
8:25 AM
Berkenblit Anna (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
8:24 AM
ImmunoGen (Issuer)
Ryll Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
8:10 AM
ImmunoGen (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
02/05/2020
10:45 AM
BlackRock Inc. (Filed by)
ImmunoGen (Subject)
Form SC 13G/A
01/27/2020
3:13 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2020
3:07 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2020
3:05 PM
ImmunoGen (Filer)
Form 424B5
01/22/2020
3:09 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2020
3:07 PM
ImmunoGen (Filer)
Form 424B5
01/13/2020
5:07 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2020
3:39 PM
FOSTER DAVID G (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:39 PM
ImmunoGen (Issuer)
Wingrove Theresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
8:27 AM
Goldberg Mark Alan (Reporting)
ImmunoGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
8:27 AM
ImmunoGen (Issuer)
MITCHELL DEAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
12:34 PM
ImmunoGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/20/2019
12:32 PM
ImmunoGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/20/2019
12:30 PM
ImmunoGen (Filer)
Form S-8 POS
12/20/2019
12:28 PM
ImmunoGen (Filer)
Form S-8 POS
12/20/2019
12:24 PM
ImmunoGen (Filer)
Form S-8 POS
12/20/2019
12:22 PM
ImmunoGen (Filer)
Form S-8 POS
12/20/2019
6:03 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
5:37 AM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
1:08 PM
ImmunoGen (Filer)
Form CT ORDER
12/06/2019
12:52 PM
ImmunoGen (Filer)
Form CT ORDER
11/26/2019
3:45 PM
ImmunoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.